Research has a pivotal role in cancer control planning as it will lead to the development of evidence-based strategies for cancer prevention and control relevant to Africa
Cancer research programmes should be multi-disciplinary and contain a research–career component for the development of African scientists as research leaders and mentors, which will lead to sustainable research programmes
International funding agencies and pharmaceutical companies should support the creation of long-term funding to foster rigorous and innovative investigator-initiated research
The formation of North–South and South–South partnerships and networks is essential for the creation of the infrastructure and environment needed to promote research
African scientists should engage country communities and policy-makers to promote community and country ownership of research programmes
Cancer research should be accompanied by the highest levels of ethical, legal and socially appropriate standards to ensure the protection of patients
Cancer research in Africa will have a pivotal role in cancer control planning in this continent. However, environments (such as those in academic or clinical settings) with limited research infrastructure (laboratories, biorespositories, databases) coupled with inadequate funding and other resources have hampered African scientists from carrying out rigorous research. In September 2012, over 100 scientists with expertise in cancer research in Africa met in London to discuss the challenges in performing high-quality research, and to formulate the next steps for building sustainable, comprehensive and multi-disciplinary programmes relevant to Africa. This was the first meeting among five major organizations: the African Organisation for Research and Training in Africa (AORTIC), the Africa Oxford Cancer Foundation (AfrOx), and the National Cancer Institutes (NCI) of Brazil, France and the USA. This article summarizes the discussions and recommendations of this meeting, including the next steps required to create sustainable and impactful research programmes that will enable evidenced-based cancer control approaches and planning at the local, regional and national levels.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917 (2010).
Sylla, B. S. & Wild, C. P. A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int. J. Cancer 130, 245–250 (2012).
Gondos, A., Brenner, H., Wabinga, H. & Parkin, D. M. Cancer survival in Kampala, Uganda. Br. J. Cancer 92, 1808–1812 (2005).
Coghill, A. E. et al. Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS 27, 2933–2442 (2013).
de Martel, C. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 13, 607–615 (2012).
Mgaya, E. M. & Kitinya, J. N. Histopathology of malignant tumours of childhood in Tanzania. East Afr. Med. J. 77, 435–439 (2000).
Msyamboza, K. P. et al. Burden of cancer in Malawi; common types, incidence and trends: national population-based cancer registry. BMC Res. Notes 5, 149 (2012).
Chintu, C., Athale, U. H. & Patil, P. S. Childhood cancers in Zambia before and after the HIV epidemic. Arch. Dis. Child. 73, 100–104; discussion 104–105 (1995).
Sinfield, R. L. et al. Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998–2003. Pediatr. Blood Cancer 48, 515–520 (2007).
Lingwood, R. J. et al. The challenge of cancer control in Africa. Nat. Rev. Cancer 8, 398–403 (2008).
WHO. National cancer control programmes: policies and managerial guidelines. 2nd edn (WHO, Geneva, 2002).
Kirigia, J. M. & Wambebe, C. Status of national health research systems in ten countries of the WHO African Region. BMC Health Serv. Res. 6, 135 (2006).
Kingham, T. P. et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 14, e158–e167 (2013).
Irikefe, V. et al. Science in Africa: the view from the front line. Nature 474, 556–559 (2011).
Ginsberg, G. M., Lauer, J. A., Zelle, S., Baeten, S. & Baltussen, R. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 344, e614 (2012).
Regional Committee for Africa, WHO. Health financing: a strategy for the African region. (56 session, Addis Ababa, Ethiopia, 2006).
Goldie, S. J. Health economics and cervical cancer prevention: a global perspective. Virus Res. 89, 301–309 (2002).
Peprah, E. & Wonkman, A. Biomedical research, a tool to address the health issues that affect African populations. Global Health 9, 50 (2013).
Yusuf, S., Baden, T. & Prieto-Godino, L. L. Bridging the gap: establishing the necessary infrastructure and knowledge for teaching and research in neuroscience in Africa. Metab. Brain Dis. http://dx.doi:10.1007/s11011-013-9443-x.
Adesina, A. et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 14, e152–e157 (2013).
John, T. A. Facilities available for biomedical science research in the public universities in Lagos, Nigeria. Niger. Postgrad. Med. J. 17, 6–14 (2010).
Eunice Kennedy Shriver National Institute of Child. Health and Human Development, National Institute of Health. Biomedical/Biobehavioral Research Administrator Development Program [online], (2012).
Office of the Director. National Institutes of Health. NIH Record—BRAD trains in development of research infrastructure [online], (2012).
Association of Research Administrators in Africa [online], (2009).
Hanna, T. P. & Kangolle, A. C. Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency. BMC Int. Health Hum. Rights 10, 24 (2010).
Parkin, D. M. The global burden of cancer. Semin. Cancer Biol. 8, 219–235 (1998).
Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y.-T., Ferlay, J. & Powell, J. (Eds) Cancer Incidence in Five Continents, Vol. VI (IARC Press, Lyon, 1992).
Parkin, D. M. Cancer in developing countries. Cancer Surv. 19–20, 519–561 (1994).
Parkin, D. M. F. J., Hamdi-Cherif, M., Sitas, F., Thomas, J. O., Wabinga, H. & Whelan, S. L. (Eds) Cancer in Africa: Epidemiology and Prevention (IARC Press, Lyon, 2003).
Parkin, D. M., Vizcaino, A. P., Skinner, M. E. & Ndhlovu, A. Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963–1977. Cancer Epidemiol. Biomarkers Prev. 3, 537–547 (1994).
Parkin, D. M. The role of cancer registries in cancer control. Int. J. Clin. Oncol. 13, 102–111 (2008).
Curado, M. P. et al. Cancer Incidence in Five Continents, Vol IX (IARC Press, Lyon, 2007).
Jedy-Agba, E. E. et al. The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. Cancer Epidemiol. 36, 430–435 (2012).
Jensen, O. M. & Whelan, S. Planning a cancer registry. IARC Sci. Publ. 22–28 (1991).
Parkin, D. M. The evolution of the population-based cancer registry. Nat. Rev. Cancer 6, 603–612 (2006).
African Cancer Registry Network [online], (2013).
Lansang, M. A. & Dennis, R. Building capacity in health research in the developing world. Bull. World Health Organ. 82, 764–770 (2004).
Fogarty International Center. The Medical Education Partnership Initiative [online], (2011).
H3Africa. Human Health and Heredity in Africa [online], (2011).
National Heart, Lung and Blood Institute, National Institutes of Health. United Health and NHLBI Collaborating Centers of Excellence [online], (2009).
Miller, D. et al. Knowledge dissemination and evaluation in a cervical cancer screening implementation program in Nigeria. Gynecol. Oncol. 107, S196–S207 (2007).
Roblyer, D., Richards-Kortum, R., Park, S. Y., Adewole, I. & Follen, M. Objective screening for cervical cancer in developing nations: lessons from Nigeria. Gynecol. Oncol. 107, S94–S97 (2007).
Casper, C. The increasing burden of HIV-associated malignancies in resource-limited regions. Annu. Rev. Med. 62, 157–170 (2011).
Silberner, J. The Hutch, Uganda gets creative in cancer fight. The Seattle Times (Seattle, Washington, 2012).
Gantt, S. et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr. Blood Cancer 54, 670–674 (2010).
Johnston, C. et al. Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS ONE 4, e4222 (2009).
Bateganya, M. H. et al. Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment. J. Acquir. Immune Defic. Syndr. 56, 312–319 (2011).
Goldman, J. D. et al. Measurement of the impact of antiretroviral therapy coverage on incidence of AIDS-defining malignancies in sub-Saharan Africa [abstract]. Lancet 377 (Suppl.), 969–970 a37 (2011).
Phipps, W. et al. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS ONE 5, e13936 (2010).
Huo, D. et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J. Clin. Oncol. 27, 4515–4521 (2009).
Zhang, J. et al. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Breast Cancer Res. Treat. 134, 889–894 (2012).
Morhason-Bello, I. O. et al. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol. 14, e142–e151 (2013).
Institut de formation et de Rescherche. Institut de formation et de Rescherche en Urologie [online], (2014).
Rebbeck, T. R. et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer 2013, 560857 (2013).
African Organization for Research and Training Cancer. HPV Cervical Cancer Network in Francophone Africa [online], (2013).
Denny, L. Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century. Int. J. Gynaecol. Obstet. 119 (Suppl. 1), S80–S84 (2012).
Viviani, S. et al. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol. Biomarkers Prev. 17, 3216–3223 (2008).
Peto, T. J. et al. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986–1990) and in the nationwide immunisation program. BMC Infect. Dis. 14, 7 (2014).
Fackenthal, J. D. et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. Int. J. Cancer 131, 1114–1123 (2012).
Arowolo, O. A. et al. Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study. Breast J. 19, 470–477 (2013).
Zheng, Y. et al. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis 34, 1520–1528 (2013).
Adebamowo, C. A. et al. Obesity and height in urban Nigerian women with breast cancer. Ann. Epidemiol. 13, 455–461 (2003).
Ogundiran, T. O. et al. Case-control study of body size and breast cancer risk in Nigerian women. Am. J. Epidemiol. 172, 682–690 (2010).
Fackenthal, J. D. et al. Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J. Med. Genet. 42, 276–281 (2005).
Oluwasola, A. O. et al. Use of web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution. Ann. Diagn. Pathol. 17, 526–530 (2013).
Tindana, P. O. et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 4, e273 (2007).
Ogwang, M. D., Bhatia, K., Biggar, R. J. & Mbulaiteye, S. M. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int. J. Cancer 123, 2658–2663 (2008).
Ogwang, M. D., Zhao, W., Ayers, L. W. & Mbulaiteye, S. M. Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch. Pathol. Lab. Med. 135, 445–450 (2011).
Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116–120 (2012).
Baik, S. et al. A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect. Agent Cancer 7, 5 (2012).
Mbulaiteye, S. M. et al. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet 375, 1661–1663 (2010).
Aka, P. et al. Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr. Blood Cancer 59, 1234–1238 (2012).
National Cancer Institute. The Epidemiology or Burkitt Lymphoma in East African Children and Minors (EMBLEM) [online], (2010).
Harif, M., Traore, F., Hessissen, L., Moreira, C. & Atteby, J. J. Challenges for paediatric oncology in Africa. Lancet Oncol. 14, 279–281 (2013).
Michener, L. et al. Aligning the goals of community-engaged research: why and how academic health centers can successfully engage with communities to improve health. Acad. Med. 87, 285–291 (2012).
Odedina, F. T. et al. The African cancer advocacy consortium: shaping the path for advocacy in Africa. Infect. Agent Cancer 8 (Suppl. 1), S8 (2013).
Segal, R., Odedina, F. T. & Pressey, S. Proceedings of the international workshop on cancer advocacy for african countries. Infect. Agent Cancer 8 (Suppl. 1), 8 (2013).
Mano, M. S., Rosa, D. D. & Dal Lago, L. Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand? Eur. J. Cancer 42, 2675–2677 (2006).
Arai, R. J., Mano, M. S., de Castro, G. Jr, Diz Mdel, P. & Hoff, P. M. Building research capacity and clinical trials in developing countries. Lancet Oncol. 11, 712–713 (2010).
Hanna, M. et al. Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience. Clin. Trials 10, 300–318 (2013).
Fogarty International Center. International Research Ethics Education and Curriculum Development Award [online], (2012).
Agence Nationale de recherches sur le sida et les hepatites virale. Ethic Charter for Research in Developing Countries, 1–12 (Paris, France, 2008).
Glass, R. International research ethics education. J. Empir. Res. Hum. Res. Ethics 8, 1–2 (2013).
Adebamowo, C. A., Mafe, M. A., Yakubu, A. A., Adekeye, J. M. & Jiya, J. J. Developing ethical oversight of research in developing countries: case study in Nigeria. Harvard Health Policy Review 8, 96–106 (2007).
Yakubu, A. & Adebamowo, C. A. Implementing National System of Health Research Ethics Regulations: The Nigerian Experience. BEOnline 1, 4–15 (2012).
Olliaro, P. & Smith, P. G. The European and developing countries clinical trials partnership. J. HIV Ther. 9, 53–56 (2004).
We would like to thank all of the attendees of the “Cancer in Africa: building transnational research collaborations” for their tremendous contribution to the discussions during the meeting.
The authors declare no competing financial interests.
About this article
Cite this article
Adewole, I., Martin, D., Williams, M. et al. Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol 11, 251–259 (2014). https://doi.org/10.1038/nrclinonc.2014.37
JCO Global Oncology (2021)
Cancer incidence and treatment utilization patterns at a regional cancer center in Tanzania from 2008-2016: Initial report of 2,772 cases
Cancer Epidemiology (2020)
Moving towards an evidence-informed cancer control strategy: A scoping review of oncology research in Kenya
Journal of Cancer Policy (2020)
Annals of Global Health (2020)
<p>Economic Burden and Predictors of Cost Variability Among Adult Cancer Patients at Comprehensive Specialized Hospitals in West Amhara, Northwest Ethiopia, 2019</p>
Cancer Management and Research (2020)